person · Reporting owner
Murphy Patrick Michael
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DEXCOM INCDXCM · Entity 3114 | EVP, Chief Legal Officer | September 09, 2021 | September 14, 2021 |
| iRhythm Holdings, Inc.IRTC · Entity 1499 | CBO and CLO | August 07, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DEXCOM INC
Report date September 09, 2021 · Filed September 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,254 |
Last balance in matching sequence
After 2021-09-09 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2021-09-09 · Sale · Disposed 975 · Balance 16,266 F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2: Included in this number are 13,461 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,953 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Row 2 · 2021-09-09 · Sale · Disposed 12 · Balance 16,254 F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2: Included in this number are 13,461 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,953 of which were granted on March 8, 2019 and shall vest through March 8, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2: Included in this number are 13,461 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,953 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
iRhythm Holdings, Inc.
Report date August 07, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 69,699 |
Ending reported balance
After 2026-08-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-07 · Grant · Acquired 13,589 · Balance 76,792 F1: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023. Row 2 · 2026-08-10 · Sale · Disposed 7,093 · Balance 69,699 F2: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023.
F2: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2020 Filed Mar 10, 2020 22:49 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 8,811 | $0.00 | $8.81 |
DisclosureSEC source: 0001093557-20-000056 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · * 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,258 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock. F2 · balance_after: Included in this number are 22,225 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 7,809 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,605 of which were granted on March 8, 2018 and shall vest through March 8, 2021. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 00:53 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $240.59 | $120,295.00 |
DisclosureSEC source: 0001093557-20-000023 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP, Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,447 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 22,016 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,408 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1,894 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| January 09, 2020 Filed Jan 11, 2020 01:03 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 500 | $235.01 | $117,505.00 |
DisclosureSEC source: 0001093557-20-000008 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP, Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,947 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 22,016 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,408 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1,894 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 01:42 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $226.51 | $90,604.00 |
DisclosureSEC source: 0001093557-19-000255 · edgardoc.xml · nonDerivative · entry 4 Murphy Patrick Michael · CIK 0001692785 · SVP, Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,447 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $226.07 to $226.88. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 22,016 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,408 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1,894 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 01:42 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,219 | $225.55 | $274,950.20 |
DisclosureSEC source: 0001093557-19-000255 · edgardoc.xml · nonDerivative · entry 3 Murphy Patrick Michael · CIK 0001692785 · SVP, Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,847 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $225.05 to $226.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 22,016 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,408 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1,894 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 01:42 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,999 | $224.36 | $448,495.64 |
DisclosureSEC source: 0001093557-19-000255 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · SVP, Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,066 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $224.01 to $225.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 22,016 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,408 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1,894 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 01:42 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,900 | $223.31 | $424,296.41 |
DisclosureSEC source: 0001093557-19-000255 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP, Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,065 F1 · shares: On September 10, 2019, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $223.01 to $224.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 22,016 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,408 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1,894 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| September 09, 2019 Filed Sep 12, 2019 01:28 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 2,359 | $150.11 | $354,112.08 |
DisclosureSEC source: 0001093557-19-000194 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,965 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · balance_after: Included in this number are 22,016 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,408 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1,894 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| September 09, 2019 Filed Sep 12, 2019 01:28 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 136 | $145.48 | $19,784.60 |
DisclosureSEC source: 0001093557-19-000194 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,324 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $145.46 to $145.49. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 22,016 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 8,408 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 1,894 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| June 10, 2019 Filed Jun 11, 2019 22:12 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $127.03 | $50,812.00 |
DisclosureSEC source: 0001093557-19-000158 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,460 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 26,711 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 11,210 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 3,787 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:51 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $116.92 | $46,768.00 |
DisclosureSEC source: 0001093557-19-000121 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,860 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 26,711 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 11,210 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 3,787 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| April 10, 2019 Filed Apr 12, 2019 21:50 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $115.05 | $46,020.00 |
DisclosureSEC source: 0001093557-19-000095 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,260 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 26,711 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 11,210 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 3,787 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 23:01 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 659 | $142.79 | $94,100.06 |
DisclosureSEC source: 0001093557-19-000083 · edgardoc.xml · nonDerivative · entry 4 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,660 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 26,711 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 11,210 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 3,787 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 23:01 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 236 | $142.79 | $33,698.96 |
DisclosureSEC source: 0001093557-19-000083 · edgardoc.xml · nonDerivative · entry 3 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,319 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 26,711 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 11,210 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 3,787 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 23:01 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 2,201 | $142.79 | $314,285.63 |
DisclosureSEC source: 0001093557-19-000083 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,555 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 26,711 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 11,210 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 3,787 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 23:01 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 866 | $142.79 | $123,658.05 |
DisclosureSEC source: 0001093557-19-000083 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,756 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 26,711 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 11,210 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 3,787 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 00:46 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 11,714 | $0.00 | $11.71 |
DisclosureSEC source: 0001093557-19-000062 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,622 F3 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 24 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock. F2 · balance_after: Included in this number are 26,711 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 11,210 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 3,787 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 00:46 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $141.56 | $56,624.00 |
DisclosureSEC source: 0001093557-19-000062 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,908 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 26,711 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 11,210 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 3,787 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:46 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $142.76 | $57,104.00 |
DisclosureSEC source: 0001093557-19-000019 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,308 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:24 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $142.76 | $57,104.00 |
DisclosureSEC source: 0000899243-19-003373 · doc4.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,308 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| January 10, 2019 Filed Jan 15, 2019 02:42 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $138.75 | $55,500.00 |
DisclosureSEC source: 0001093557-19-000007 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP, GC & Chief Compliance Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,708 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| December 10, 2018 Filed Dec 13, 2018 02:09 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $121.90 | $48,760.00 |
DisclosureSEC source: 0001093557-18-000252 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP, GC & Chief Compliance Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,108 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 01:14 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $148.11 | $59,244.00 |
DisclosureSEC source: 0001093557-18-000236 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP, GC & Chief Compliance Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,508 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| October 10, 2018 Filed Oct 12, 2018 20:11 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $122.20 | $48,880.00 |
DisclosureSEC source: 0001093557-18-000217 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP, GC & Chief Compliance Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,908 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:20 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 400 | $143.35 | $57,340.00 |
DisclosureSEC source: 0001093557-18-000197 · edgardoc.xml · nonDerivative · entry 3 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,308 F3 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:20 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,021 | $143.76 | $146,774.06 |
DisclosureSEC source: 0001093557-18-000197 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,708 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:20 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 951 | $143.76 | $136,711.20 |
DisclosureSEC source: 0001093557-18-000197 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,729 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| August 10, 2018 Filed Aug 15, 2018 00:32 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 2,300 | $125.18 | $287,922.05 |
DisclosureSEC source: 0001093557-18-000165 · edgardoc.xml · nonDerivative · entry 4 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,680 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $124.88 to $125.69. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 29,391 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 7,574 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 5,000 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| August 10, 2018 Filed Aug 15, 2018 00:32 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 7,500 | $124.36 | $932,689.50 |
DisclosureSEC source: 0001093557-18-000165 · edgardoc.xml · nonDerivative · entry 3 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,980 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $123.88 to $124.83. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 29,391 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 7,574 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 5,000 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| August 10, 2018 Filed Aug 15, 2018 00:32 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,600 | $123.48 | $197,560.00 |
DisclosureSEC source: 0001093557-18-000165 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,480 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $122.84 to $123.74. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 29,391 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 7,574 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 5,000 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| August 10, 2018 Filed Aug 15, 2018 00:32 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,100 | $121.94 | $134,137.96 |
DisclosureSEC source: 0001093557-18-000165 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,080 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $121.65 to $122.49. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 29,391 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 7,574 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 5,000 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| March 12, 2018 Filed Mar 15, 2018 01:03 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 1,329 | $60.73 | $80,710.97 |
DisclosureSEC source: 0001093557-18-000059 · edgardoc.xml · nonDerivative · entry 3 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,180 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 29,391 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 7,574 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 5,000 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| March 12, 2018 Filed Mar 15, 2018 01:03 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 1,562 | $60.73 | $94,861.20 |
DisclosureSEC source: 0001093557-18-000059 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,509 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 29,391 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 7,574 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 5,000 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| March 12, 2018 Filed Mar 15, 2018 01:03 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 877 | $60.73 | $53,260.74 |
DisclosureSEC source: 0001093557-18-000059 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,071 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 29,391 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 7,574 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 5,000 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| March 08, 2018 Filed Mar 13, 2018 01:32 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 16,817 | $0.00 | $16.82 |
DisclosureSEC source: 0001093557-18-000035 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,948 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 24 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock. F2 · balance_after: Included in this number are 29,391 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 7,574 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 5,000 of which were granted on March 8, 2016 shall vest through March 8, 2019. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:37 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 1,322 | $71.81 | $94,937.31 |
DisclosureSEC source: 0001093557-17-000197 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,131 F1 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 23,092 unvested restricted stock units, 11,361 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 7,500 of which were granted on March 8, 2016 shall vest through March 8, 2019 and 4,231 of which were granted on March 8, 2015 and shall vest through March 8, 2018. Read SEC document |
| March 10, 2017 Filed Mar 11, 2017 01:45 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 2,209 | $77.55 | $171,309.28 |
DisclosureSEC source: 0001093557-17-000060 · edgardoc.xml · nonDerivative · entry 4 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,453 F3 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 25,592 unvested restricted stock units, 11,361 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 10,000 of which were granted on March 8, 2016 shall vest through March 8, 2019 and 4,231 of which were granted on March 8, 2015 and shall vest through March 8, 2018. Read SEC document |
| March 10, 2017 Filed Mar 11, 2017 01:45 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 1,611 | $77.55 | $124,934.02 |
DisclosureSEC source: 0001093557-17-000060 · edgardoc.xml · nonDerivative · entry 3 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,662 F3 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 25,592 unvested restricted stock units, 11,361 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 10,000 of which were granted on March 8, 2016 shall vest through March 8, 2019 and 4,231 of which were granted on March 8, 2015 and shall vest through March 8, 2018. Read SEC document |
| March 10, 2017 Filed Mar 11, 2017 01:45 UTC | DEXCOM INC DXCM · Entity 3114 | Disposition to issuerCommon Stock | 2,216 | $77.55 | $171,852.13 |
DisclosureSEC source: 0001093557-17-000060 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,273 F3 · shares: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted. F2 · balance_after: Included in this number are 25,592 unvested restricted stock units, 11,361 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 10,000 of which were granted on March 8, 2016 shall vest through March 8, 2019 and 4,231 of which were granted on March 8, 2015 and shall vest through March 8, 2018. Read SEC document |
| March 08, 2017 Filed Mar 11, 2017 01:45 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 11,361 | $0.00 | $11.36 |
DisclosureSEC source: 0001093557-17-000060 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · VP, Legal Aff & Chf Compl Ofcr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,489 F1 · shares: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 24 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock. F2 · balance_after: Included in this number are 25,592 unvested restricted stock units, 11,361 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 10,000 of which were granted on March 8, 2016 shall vest through March 8, 2019 and 4,231 of which were granted on March 8, 2015 and shall vest through March 8, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.